Aussie and kiwi slide, yen up on Moderna CEO's Omicron warning



By Kevin Buckland and Alun John

Nov 30 (Reuters) - Risk-sensitive currencies slid and safe havens gained in the Asian afternoon on Tuesday, reversing direction after Moderna's CEO said COVID-19 vaccines are unlikely to be as effective against the Omicron variant as it has been with other types.

"There is no world, I think, where (the effectiveness ) is the same level . . . we had with Delta," Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.

The Australian dollar AUD=D3 slid 0.65% to a new 12-month month low of $0.7093, and the New Zealand dollar NZD=D3 lost 0.6% to $0.6783 after the interview was published, heading for its worst month since May 2015.

The yen JPY= gained 0.3%, with one dollar fetching as little as 112.97 yen matching its two week low hit Monday.

Earlier the Japanese currency had lost ground and antipodean currencies had gained as traders took comfort from very early hints that Omicron might be milder than feared as well as from remarks by President Joe Biden that the United States would not reinstate lockdowns.

But the World Health Organization warned of a "very high" risk of infection surges from Omicron, and countries around the world have reacted quickly to tighten border controls.

The euro EUR= was steady at $1.131 while sterling GBP=D3 was little changed at $1.3315

The single currency slumped to a nearly 17-month trough of $1.11864 last week as European Central Bank policy makers stuck to their dovish stance in the face of heated inflation.

The latest reading on euro area consumer prices is due later Tuesday.

Prior to Omicron's arrival, the main driver of currency moves was how traders perceived the different speeds at which global central banks would end pandemic era stimulus and raise interest rates as they looked to combat rising inflation without choking off growth.

In testimony prepared for Congress later Tuesday, Fed Chair Jerome Powell said Omicron could cause inflation pressures to last longer.

That would potentially speed the need for rate hikes, whereas traders initially reacted to Omicron's discovery by pushing back bets for Fed tightening because of the risk to growth.

Money markets currently see good odds of a first rate rise in July, but one is not fully priced until September. <FED WATCH>

Looming Fed rate hikes had previously been supporting the dollar.

"The dollar weakness we saw on Friday shows that a lot of the dollar strength was more a function of Fed thinking and Fed pricing. On any other day you would have expected the US dollar's safe haven credentials to have been prominent," said Ray Atrill head of FX strategy at NAB.

The dollar index =USD , which measures the currency against six major rivals, last traded at 96.075, back near Friday's low of 95.973, when it suffered its biggest one-day drop since May.



World FX rates Link



Reporting by Kevin Buckland Alun John and Tom Westbrook;
Editing by Lincoln Feast & Shri Navaratnam


Mga Kaugnay na Asset


Pinakabagong Balita

Financial Times - Jan. 21

G
H

Britain braces for big rise in fuel poverty: Kemp


Australia, New Zealand corporate earnings week ahead

A

Gold steadies, heads for second straight weekly gain

G
S

China Evergrande says hiring more advisers to help deal with debt

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Ang iyong kapital ay maaaring malugi. Ang mga produktong naka-leverage ay maaaring hindi para sa lahat. Tingnan ang aming Risk Disclosure.